Page last updated: 2024-12-08
furbenicillin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
furbenicillin: RN given refers to (2S-(2alpha,5alpha,6beta(S*)))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 171362 |
| MeSH ID | M0071831 |
Synonyms (8)
| Synonym |
|---|
| furbenicillin |
| (2s,5r,6r)-6-[[2-(furan-2-carbonylcarbamoylamino)-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((((((2-furancarbonyl)amino)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta(s*)))- |
| 54661-82-4 |
| bl-p1597 |
| 6-(d-alpha(3-(2-furoyl)ureido)phenylacetamido)penicillinic acid potassium salt |
| DTXSID60969947 |
| 6-[(2-{[{[(furan-2-yl)(hydroxy)methylidene]amino}(hydroxy)methylidene]amino}-1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
Research Excerpts
Overview
Furbenicillin is a broad-spectrum semisynthetic penicillin with strong antibacterial activity against Gram-negative bacteria.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Furbenicillin is a broad-spectrum semisynthetic penicillin with strong antibacterial activity against Gram-negative bacteria. " | ( Isolation, identification and characterization of related substances in furbenicillin. Chang, Y; Feng, YC; Hu, C; Tian, Y; Zhang, DS, 2015) | 2.09 |
| "Furbenicillin is a broad-spectrum semisynthetic penicillin with strong antibacterial activity against Gram-negative bacteria. " | ( [Determination of furbenicillin sodium and its related substances by HPLC]. Chang, Y; Hu, CQ; Ma, Y; Tian, Y, 2015) | 2.19 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||